SIAH3 and pancreatic neoplasm: Cox hazard analyses of the TCGA and CPTAC pancreatic cancer cohorts identified SIAH3 as a positive prognostic marker for overall survival (HR = 0.4 and HR = 0.36, respectively), as shown in Table 2.